This frequency is much higher than the frequency of 20% observed in our tumor samples and the 8% reported in the Cancer Genome Atlas.16 However, the NOTCH1 mutation frequency reported here is consistent with other cancer cohort studies, in terms of both lower mutation frequency in tumor tissues14, 16 and higher mutation frequency in cfDNAs.21, 35. This evidence concerns the gene NOTCH1 and cancer.